Artificial Heart Market Size To Reach $5.94 Billion By 2030

Artificial Heart Market Growth & Trends

The global artificial heart market size is expected to reach USD 5.94 billion by 2030, registering a CAGR of 11.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is experiencing significant growth, driven by various factors such as the increasing burden of cardiovascular diseases, technological advancements in the field, a growing geriatric population, and lifestyle changes leading to higher cardiovascular risks. As the global population ages, there is an increased incidence of cardiac issues among older individuals. This demographic trend contributes to the demand for artificial hearts as a treatment option for heart failure and other conditions.

The global burden of CVDs is increasing, driven by the aging population, sedentary lifestyles, and unhealthy diets. According to an article by NCBI in May 2022, 92.1 million Americans are affected by some form of CVD, and it is predicted that 43.9% will have some type of CVD by 2030. Similarly, according to the British Heart Foundation's July 2022 report, 4 million men and 3.6 million women lived with heart and circulatory diseases in 2021. Continued investment in research aimed at improving cardiac patient outcomes drives adoption rates for artificial hearts. In January 2024, CARMAT introduced a new software enhancement for its artificial heart Aeson, aiming to enhance its safety profile by enabling real-time defect detection and modifying control to provide continuous patient care.

 Request a free sample copy or view report summary: Artificial Heart Market Report

Artificial Heart Market Report Highlights

• Based on type, the left ventricular assist device (LVAD) segment held the largest market share of 77.40% in 2023. The rising prevalence of heart failure globally has contributed significantly to the growth of the LVAD market

• Based on therapy, the destination therapy segment accounted for the largest revenue share of 61.8% in 2023 and is expected to witness the fastest CAGR of 11.8% during the forecast period. owing to the increasing prevalence of advanced heart failure patients who are ineligible for heart transplantation or other therapies

• In 2023, North America dominated the market with a share of 64.1% due to the advanced healthcare infrastructure, favorable reimbursement policies, and technological advancements in the region. The presence of major market players such as Abbott, BiVacor and SynCardia dominates the market in this region

Artificial Heart Market Segmentation

Grand View Research has segmented the global artificial heart market based on type, therapy, and region:

Artificial Heart Type Outlook (Revenue, USD Billion, 2018 - 2030)

• LVADs

• Heart-lung Machine

• Total Artificial Heart

Artificial Heart Therapy Outlook (Revenue, USD Billion, 2018 - 2030)

• Bridge To Transplant

• Destination Therapy

• Bridge To Decision

• Others

Artificial Heart Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Artificial Heart Market

• SynCardia Systems, LLC

• CARMAT

• BiVACOR Inc.

• RealHeart

• Abbott

• ABIOMED (Johnson & Johnson Services Inc)

• Jarvik Heart, Inc.

• LivaNova PLC

• Getinge

• Terumo Corporation